1. December 2022. News

On the 1st of December 2022. new Orthokin center is licensed in Euromedik medical center where therapy will be applied for all standard indications (knee, hip, shoulder osteoarthritis, tendinitis) including spine (disc prolapse, faset osteoarthritis, local back pain). First Orthokin therapy was applied by Ass. dr sci. med. Slavica Prodanovic. Introducing Euromedik as a new licensed center, Othokin therapy is now available in all leading private healthcare institutions in Serbia and accessible to even larger number of patience.

5. April 2022. News

On the 5th of April 2021 new Orthokin center was licensed and opened in Zdravlje Health policlinic . Orthokin therapy will be provided by orthopedist dr Miodrag Bogosavljević. In near future we expect other orthopedists from this policlinic to get involved in Orthokin application. We wish many success and good treatment results to our associates from Zdravlje Health.

7. December 2021. News0

OsteoNS 2021. was held in Novi Sad on 9.11.2021.

As part of the lecture “Intraarticular treatment of osteoarthritis under ultrasound control” prof. Nemanja Damjanov, a rheumatologist, spoke about the results of the study, “Efficacy and safety of ACS (Orthokin) injections compared to Betamethasone and placebo injections in the treatment of chronic shoulder pain due to supraspinatus tendinopathy“.

8. July 2018. News0

The II International Symposium of Molecular Medicine was held, where lectures on positive experiences in the application of Orthokin therapy were very much noted:

– regarding shoulder diseases – Lectures were held by prof. dr. Nemanja Damjanov (rheumatologist) and clin. ass. dr. Vladan Stevanović (orthopedist);

– regarding lumbar pain (discus hernia, radiculopathy) – dr. Marko Marković (neurosurgeon).

17. May 2017. News0

Visit of the inventor of the Orthokin method prof. dr Peter Wehling to Belgrade and Podgorica. He treated Pope John Paul II, six best female tennis players, Bundesliga soccer players. He enabled the basketball player Kobe Bryant to extend his career. He spoke about the advantages and possibilities of this treatment method to his colleagues at the Institute of Rheumatology.